Novel xeno-free and serum-free culturing condition to improve piggyBac transposon-based CD19 chimeric antigen receptor T-cell production and characteristics
Cytotherapy（2023）
摘要
Our study supports the usage of xeno-free serum replacement as an alternative source of serum supplements for piggyBac-based CAR T-cell expansion.
更多查看译文
关键词
CD19,Chimeric antigen receptor T cells,Fetal bovine serum,Human AB serum,PiggyBac transposon,Serum replacement reagent
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要